Nektar Therapeutics | NKTR - Cash And Equivalent


Nektar Therapeutics reported $15.12M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 113.6M 24.47M Mar/2026
ALKERMES USD 351.55M 37.02M Mar/2026
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Amgen USD 12.04B 2.91B Mar/2026
Baxter International USD 2.02B 51M Mar/2026
BioCryst Pharmaceuticals USD 335.91M 251.83M Dec/2025
Biogen USD 3.38B 374.2M Mar/2026
Bristol-Myers Squibb USD 9.57B 635M Mar/2026
Cara Therapeutics USD 21.42M 770K Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Eisai JPY 301.65B 16.27B Sep/2025
Eli Lilly USD 5.28B 1.99B Mar/2026
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Exelixis USD 482.49M 106.19M Dec/2025
Gilead Sciences USD 7.56B 234M Dec/2025
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Grifols EUR 979.78M 334.84M Dec/2024
Halozyme Therapeutics USD 133.82M 285.84M Dec/2025
Incyte USD 4.02B 435.22M Mar/2026
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
Ironwood Pharmaceuticals USD 140.41M 47.56M Sep/2025
Karyopharm Therapeutics USD 60.54M 22.87M Dec/2025
MacroGenics USD 57.22M 22.91M Dec/2025
Merck USD 5.33B 9.24B Mar/2026
Nektar Therapeutics USD 15.12M 25.92M Dec/2025
Neurocrine Biosciences USD 266.5M 446.5M Mar/2026
Novartis USD 6.88B 4.56B Mar/2026
Pfizer USD 1.7B 561M Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025
Takeda JPY 654.94B 26.55B Dec/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025
Xencor USD 54.07M 25.78M Dec/2025